An Overview on The Pandemic Coronavirus Disease 2019 (COVID-19) Outbreak

Mariwan Abdulla Hama Salih

doi:10.24017/covid.4

Authors

Mariwan Abdulla Hama Salih Medical Laboratory Department, Technical College of Health, Sulaimani Polytechnic University, Sulaimani, Iraq

Abstract

The current review covered most of the researches have been done since the new coronavirus found in Wuhan city of China at the end of December 2019 up to date by considering the most beneficial ones for our society. The severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2 is a virus that potentially acts on the human respiratory system. It is first found in animal then transmitted into human. The virus can be transmitted between human to human via close contact or from the tiny droplet while coughing or sneezing. WHO characterized the situation by pandemic global concern because the virus spread over 200 territories and more than millions peoples were infected and over two hundred thousand people deceased as a result of COVID-19. At the moment nothing can stop the virus from spreading, neither vaccine nor medicines were found to stop the virus and secure life of people of the planet. The aim of the present review was to show the main feature of the SARS-CoV-2 and to find the common statements between the previously published studies on the output of their works. The other objective of this review was to encourage publics to treat the virus in safe way based on the discovery by researchers toward secure life of million peoples that could be infected by the 2019 new coronavirus. This review were summarized several researches about the SARS-CoV-2 since its appearance to present time May 2020. Several reports from WHO, CDC and FDA were included about spreading or the way of transmission, causes, prevention, diagnosis and risk factors of the COVID-19. The current review find the common statements about different aspects of the 2019 new coronavirus that could be help the new research to benefit from these statement for further investigations. This review showed that urgent steps for the current time to secure life of millions peoples is to quarantines people at home and governmental authorities have to take the responsibilities of this steps and to encourage people to stay at home and teach them the self-prevention is a better treatment for all humanities.

Keywords:

COVID-19, SARS-COV-2, Coronavirus Diseases 2019, 2019-nCoV, Coronavirus, SPU.

References

[1] T. Zhang, Q. Wu, and Z. Zhang, "Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak," Current Biology, vol. 30, pp. 1346-1351.e2, 2020/04/06/ 2020.
https://doi.org/10.1016/j.cub.2020.03.022
[2] S. Ali, T. Hama-Soor, M. Babakir-Mina, S. Dimonte, and F. Greco, "Is It Scaly Anteater or Bat A Real Origin of The 2019-Novel CoV: A Probable Hypothesis? ," Kurdistan Journal of Applied Research, vol. 5, pp. 1-12, 2020.
https://doi.org/10.24017/covid.1
[3] WHO, "Coronavirus Diseases 2019 (COVID-19)- Situation Report-22," WHO11- February 2020.
[4] WHO, "Coronavirus diseases 2019 (COVID-19)- Situation Report-52," Report12-March 2020.
[5] CDC. (2020). Human Coronavirus. Available: https://www.cdc.gov/coronavirus/types.html
[6] T. Chen, D. Wu, H. Chen, W. Yan, D. Yang, G. Chen, X. Luo, J. Zhao, and Q. Ning, "Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study," BMJ, vol. 368, p. m1091, 2020.
https://doi.org/10.1136/bmj.m1091
[7] T. Zhen-Dong, T. An, L. Ke-Feng, L. Peng, W. Hong-Ling, Y. Jing-Ping, Z. Yong-Li, and Y. Jian-Bo, "Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020," Emerging Infectious Disease journal, vol. 26, 2020.
https://doi.org/10.3201/eid2605.200198
[8] C. P. Davis. (2020, 30 April). COVID-19 (Coronavirus, 2019-nCoV). Available: https://www.medicinenet.com/wuhan_coronavirus_2019-ncov/article.htm
[9] Q. Li, X. Guan, P. Wu, X. Wang, L. Zhou, Y. Tong, R. Ren, K. S. M. Leung, E. H. Y. Lau, J. Y. Wong, X. Xing, N. Xiang, Y. Wu, B. J. Cowling, B. Yang, G. M. Leung, and Z. Feng, "Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia," New England Journal of Medicine, vol. 382, pp. 1199-1207, 2020.
https://doi.org/10.1056/NEJMoa2001316
[10] C. Jing, S. Wenjie, H. Jianping, G. Michelle, W. Jing, and H. Guiqing, "Indirect Virus Transmission in Cluster of COVID-19 Cases, Wenzhou, China, 2020," Emerging Infectious Disease journal, vol. 26, 2020.
https://doi.org/10.3201/eid2606.200412
[11] M. krg, "Coronavirus 2019- Situation Update," Ministry of Health, https://gov.krd/coronavirus-en/situation-update/29 April 2020.
[12] D. Zhanwei, W. Lin, C. Simon, X. Xiaoke, W. Xianwen, J. C. Benjamin, and M. Lauren Ancel, "Risk for Transportation of 2019 Novel Coronavirus Disease from Wuhan to Other Cities in China," Emerging Infectious Disease journal, vol. 26, 2020.
https://doi.org/10.3201/eid2605.200146
[13] G. Kampf, D. Todt, S. Pfaender, and E. Steinmann, "Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents," Journal of Hospital Infection, vol. 104, pp. 246-251, 2020.
https://doi.org/10.1016/j.jhin.2020.01.022
[14] N. van Doremalen, T. Bushmaker, D. Morris, M. Holbrook, A. Gamble, B. Williamson, A. Tamin, J. Harcourt, N. Thornburg, S. Gerber, J. Lloyd-Smith, E. de Wit, and V. Munster, "Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1," medRxiv, p. 2020.03.09.20033217, 2020.
https://doi.org/10.1101/2020.03.09.20033217
[15] Y. Liu, Z. Ning, Y. Chen, M. Guo, Y. Liu, N. K. Gali, L. Sun, Y. Duan, J. Cai, D. Westerdahl, X. Liu, K.-f. Ho, H. Kan, Q. Fu, and K. Lan, "Aerodynamic Characteristics and RNA Concentration of SARS-CoV-2 Aerosol in Wuhan Hospitals during COVID-19 Outbreak," bioRxiv, p. 2020.03.08.982637, 2020.
https://doi.org/10.1101/2020.03.08.982637
[16] CDC, "Coronavirus Disease 2019 (COVID-19)," U.S. Centers for Disease Control and Prevention, https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html17-April 2020.
[17] B. Udugama, P. Kadhiresan, H. N. Kozlowski, A. Malekjahani, M. Osborne, V. Y. C. Li, H. Chen, S. Mubareka, J. B. Gubbay, and W. C. W. Chan, "Diagnosing COVID-19: The Disease and Tools for Detection," ACS nano, vol. 14, pp. 3822-3835, 2020.
https://doi.org/10.1021/acsnano.0c02624
[18] NCIRD, "Division of Viral Diseases," National Center for Immunization and Respiratory Diseases27 April 2020.
[19] BD. (2020, 03 April 2020). COVID-19 IgM/IgG Rapid test. Available: https://www.biomedomics.com/products/infectious-disease/covid-19-rt/
[20] T. Ai, Z. Yang, H. Hou, C. Zhan, C. Chen, W. Lv, Q. Tao, Z. Sun, and L. Xia, "Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases," Radiology, vol. 0, p. 200642.
[21] R. Patanavanich and S. A. Glantz, "Smoking is Associated with COVID-19 Progression: A Meta-Analysis," medRxiv, p. 2020.04.13.20063669, 2020.
https://doi.org/10.1101/2020.04.13.20063669
[22] J. Lighter, M. Phillips, S. Hochman, S. Sterling, D. Johnson, F. Francois, and A. Stachel, "Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission," Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, p. ciaa415, 2020.
https://doi.org/10.1093/cid/ciaa415
[23] W. Liang, W. Guan, R. Chen, W. Wang, J. Li, K. Xu, C. Li, Q. Ai, W. Lu, H. Liang, S. Li, and J. He, "Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China," The Lancet. Oncology, vol. 21, pp. 335-337, 2020.
https://doi.org/10.1016/S1470-2045(20)30096-6
[24] WHO, "Coronavirus Disease 2019 (COVID-19)," World Health Organisation https://www.who.int/news-room/q-a-detail/q-a-coronaviruses29 April 2020.
[25] B. N. Williamson, F. Feldmann, B. Schwarz, K. Meade-White, D. P. Porter, J. Schulz, N. v. Doremalen, I. Leighton, C. K. Yinda, L. Pérez-Pérez, A. Okumura, J. Lovaglio, P. W. Hanley, G. Saturday, C. M. Bosio, S. Anzick, K. Barbian, T. Cihlar, C. Martens, D. P. Scott, V. J. Munster, and E. d. Wit, "Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2," bioRxiv, p. 2020.04.15.043166, 2020.
https://doi.org/10.1101/2020.04.15.043166
[26] P. Gautret, J.-C. Lagier, P. Parola, V. T. Hoang, L. Meddeb, M. Mailhe, B. Doudier, J. Courjon, V. Giordanengo, V. E. Vieira, H. T. Dupont, S. Honoré, P. Colson, E. Chabrière, B. La Scola, J.-M. Rolain, P. Brouqui, and D. Raoult, "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial," International Journal of Antimicrobial Agents, p. 105949, 2020/03/20/ 2020.
https://doi.org/10.1101/2020.03.16.20037135
[27] NIH, "Coronavirus Disease (COVID-19) treatment guidline " National Institute of Health, https://covid19treatmentguidelines.nih.gov/29 April 2020.
[28] E. Mahase, "Covid-19: What do we know so far about a vaccine?," BMJ, vol. 369, p. m1679, 2020.
https://doi.org/10.1136/bmj.m1679
[29] K. Duan, B. Liu, C. Li, H. Zhang, T. Yu, J. Qu, M. Zhou, L. Chen, S. Meng, Y. Hu, C. Peng, M. Yuan, J. Huang, Z. Wang, J. Yu, X. Gao, D. Yu, J. Hou, Z. Shi, S. Chen, Z. Chen, X.-x. Zhang, and X. Yang, "The feasibility of convalescent plasma therapy in severe COVID-19 patients: a pilot study," medRxiv, p. 2020.03.16.20036145, 2020.
https://doi.org/10.1101/2020.03.16.20036145
[30] D. Chen, W. Xu, Z. Lei, Z. Huang, J. Liu, Z. Gao, and L. Peng, "Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report," International Journal of Infectious Diseases, vol. 93, pp. 297-299, 2020/04/01/ 2020.
https://doi.org/10.1016/j.ijid.2020.03.003